KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Receivables - Other: 2019-2020

Historic Receivables - Other for Aurinia Pharmaceuticals (AUPH) over the last 2 years, with Dec 2020 value amounting to $486,000.

  • Aurinia Pharmaceuticals' Receivables - Other rose 137.07% to $486,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $486,000, marking a year-over-year increase of 137.07%. This contributed to the annual value of $486,000 for FY2020, which is 137.07% up from last year.
  • According to the latest figures from FY2020, Aurinia Pharmaceuticals' Receivables - Other is $486,000, which was up 137.07% from $205,000 recorded in FY2019.
  • In the past 5 years, Aurinia Pharmaceuticals' Receivables - Other ranged from a high of $486,000 in FY2020 and a low of $205,000 during FY2019.
  • For the 2-year period, Aurinia Pharmaceuticals' Receivables - Other averaged around $345,500, with its median value being $345,500 (2019).
  • Data for Aurinia Pharmaceuticals' Receivables - Other shows a peak YoY skyrocketed of 137.07% (in 2020) over the last 5 years.
  • Aurinia Pharmaceuticals' Receivables - Other (Yearly) stood at $205,000 in 2019, then skyrocketed by 137.07% to $486,000 in 2020.